Chicago Wolves
While the Chicago Wolves are proud of their four league championships, they feel just as proud of their relationship with hockey fans, which enabled Chicago Wolves Charities to raise more than $4 million for local organizations.
We value your privacy
We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies.
We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.
The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ...
Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.
No cookies to display.
Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.
No cookies to display.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.
No cookies to display.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
No cookies to display.
Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.
No cookies to display.
8.
Good Genes: In a Swedish preclinical study of patients with clear-cell kidney cancer, researchers found the activity of four specific genes in the patients’ cancer cells may be able to predict the risk of tumors spreading to the skeleton, occurring in one-third of cases. The research will help scientists better understand the interaction between tumors and their microenvironment.
9.
Hand in Hand: Moderna and Merck have announced that together they will develop and sell a personalized cancer vaccine for individual patients. Moderna’s messenger RNA vaccine technology will be studied along with Merck’s Keytruda to treat patients with high-risk melanoma.
7.
Embrace Your Curls: Be careful of chemical hair-straightening products. A study by the National Institute of Environmental Health Sciences followed almost 35,000 women between age 35 and 74 to monitor risk factors for breast cancer and other conditions, and found that women who frequently used hair-straightening products were more than twice as likely to develop uterine cancer.
8.
Good Genes: In a Swedish preclinical study of patients with clear-cell kidney cancer, researchers found the activity of four specific genes in the patients’ cancer cells may be able to predict the risk of tumors spreading to the skeleton, occurring in one-third of cases. The research will help scientists better understand the interaction between tumors and their microenvironment.
9.
Hand in Hand: Moderna and Merck have announced that together they will develop and sell a personalized cancer vaccine for individual patients. Moderna’s messenger RNA vaccine technology will be studied along with Merck’s Keytruda to treat patients with high-risk melanoma.
6.
Mediterranea-yum!: Researchers concluded that a Mediterranean diet rich in fiber, mono-unsaturated fatty acids (found in oils, nuts and fish) and polyphenols (found in vegetables, fruit and whole grains) has been associated with a major improved response to immunotherapy drugs, called immune checkpoint inhibitors, in melanoma patients. This diet was also associated with progression-free survival at 12 months.
7.
Embrace Your Curls: Be careful of chemical hair-straightening products. A study by the National Institute of Environmental Health Sciences followed almost 35,000 women between age 35 and 74 to monitor risk factors for breast cancer and other conditions, and found that women who frequently used hair-straightening products were more than twice as likely to develop uterine cancer.
8.
Good Genes: In a Swedish preclinical study of patients with clear-cell kidney cancer, researchers found the activity of four specific genes in the patients’ cancer cells may be able to predict the risk of tumors spreading to the skeleton, occurring in one-third of cases. The research will help scientists better understand the interaction between tumors and their microenvironment.
9.
Hand in Hand: Moderna and Merck have announced that together they will develop and sell a personalized cancer vaccine for individual patients. Moderna’s messenger RNA vaccine technology will be studied along with Merck’s Keytruda to treat patients with high-risk melanoma.
5.
Put to the Test: A molecular test that distinguishes between benign and malignant cysts shows promising results for pancreatic cancer. Funded by the U.S. National Cancer Institute, the Pancreatic Cancer Action Network and others, PancreaSeq will help improve early detection of pancreatic cancer and avoid overtreatment.
6.
Mediterranea-yum!: Researchers concluded that a Mediterranean diet rich in fiber, mono-unsaturated fatty acids (found in oils, nuts and fish) and polyphenols (found in vegetables, fruit and whole grains) has been associated with a major improved response to immunotherapy drugs, called immune checkpoint inhibitors, in melanoma patients. This diet was also associated with progression-free survival at 12 months.
7.
Embrace Your Curls: Be careful of chemical hair-straightening products. A study by the National Institute of Environmental Health Sciences followed almost 35,000 women between age 35 and 74 to monitor risk factors for breast cancer and other conditions, and found that women who frequently used hair-straightening products were more than twice as likely to develop uterine cancer.
8.
Good Genes: In a Swedish preclinical study of patients with clear-cell kidney cancer, researchers found the activity of four specific genes in the patients’ cancer cells may be able to predict the risk of tumors spreading to the skeleton, occurring in one-third of cases. The research will help scientists better understand the interaction between tumors and their microenvironment.
9.
Hand in Hand: Moderna and Merck have announced that together they will develop and sell a personalized cancer vaccine for individual patients. Moderna’s messenger RNA vaccine technology will be studied along with Merck’s Keytruda to treat patients with high-risk melanoma.
4.
Seek a Screen: Doctors and oncologists have noted a rise in breast cancer diagnoses in younger people. According to the CDC, most breast cancer diagnoses occur in women over 50, but one in 10 women diagnosed are under the age of 45. Every person with breasts, not just those over age 50, should pay attention to their bodies and get screened.
5.
Put to the Test: A molecular test that distinguishes between benign and malignant cysts shows promising results for pancreatic cancer. Funded by the U.S. National Cancer Institute, the Pancreatic Cancer Action Network and others, PancreaSeq will help improve early detection of pancreatic cancer and avoid overtreatment.
6.
Mediterranea-yum!: Researchers concluded that a Mediterranean diet rich in fiber, mono-unsaturated fatty acids (found in oils, nuts and fish) and polyphenols (found in vegetables, fruit and whole grains) has been associated with a major improved response to immunotherapy drugs, called immune checkpoint inhibitors, in melanoma patients. This diet was also associated with progression-free survival at 12 months.
7.
Embrace Your Curls: Be careful of chemical hair-straightening products. A study by the National Institute of Environmental Health Sciences followed almost 35,000 women between age 35 and 74 to monitor risk factors for breast cancer and other conditions, and found that women who frequently used hair-straightening products were more than twice as likely to develop uterine cancer.
8.
Good Genes: In a Swedish preclinical study of patients with clear-cell kidney cancer, researchers found the activity of four specific genes in the patients’ cancer cells may be able to predict the risk of tumors spreading to the skeleton, occurring in one-third of cases. The research will help scientists better understand the interaction between tumors and their microenvironment.
9.
Hand in Hand: Moderna and Merck have announced that together they will develop and sell a personalized cancer vaccine for individual patients. Moderna’s messenger RNA vaccine technology will be studied along with Merck’s Keytruda to treat patients with high-risk melanoma.
3.
Diversifying Medicine: The Harper Cancer Research Institute partnered with the Pokagon Band of Potawatomi Indians to raise awareness about early detection in Native American communities. This will address disparities in treatment outcomes and help researchers diversify cancer tissue samples to create more personalized medicine for people of all races and ethnicities.
4.
Seek a Screen: Doctors and oncologists have noted a rise in breast cancer diagnoses in younger people. According to the CDC, most breast cancer diagnoses occur in women over 50, but one in 10 women diagnosed are under the age of 45. Every person with breasts, not just those over age 50, should pay attention to their bodies and get screened.
5.
Put to the Test: A molecular test that distinguishes between benign and malignant cysts shows promising results for pancreatic cancer. Funded by the U.S. National Cancer Institute, the Pancreatic Cancer Action Network and others, PancreaSeq will help improve early detection of pancreatic cancer and avoid overtreatment.
6.
Mediterranea-yum!: Researchers concluded that a Mediterranean diet rich in fiber, mono-unsaturated fatty acids (found in oils, nuts and fish) and polyphenols (found in vegetables, fruit and whole grains) has been associated with a major improved response to immunotherapy drugs, called immune checkpoint inhibitors, in melanoma patients. This diet was also associated with progression-free survival at 12 months.
7.
Embrace Your Curls: Be careful of chemical hair-straightening products. A study by the National Institute of Environmental Health Sciences followed almost 35,000 women between age 35 and 74 to monitor risk factors for breast cancer and other conditions, and found that women who frequently used hair-straightening products were more than twice as likely to develop uterine cancer.
8.
Good Genes: In a Swedish preclinical study of patients with clear-cell kidney cancer, researchers found the activity of four specific genes in the patients’ cancer cells may be able to predict the risk of tumors spreading to the skeleton, occurring in one-third of cases. The research will help scientists better understand the interaction between tumors and their microenvironment.
9.
Hand in Hand: Moderna and Merck have announced that together they will develop and sell a personalized cancer vaccine for individual patients. Moderna’s messenger RNA vaccine technology will be studied along with Merck’s Keytruda to treat patients with high-risk melanoma.
2.
Fungus Among Us: Research from the Weizmann Institute of Science in Israel and the University of California, San Diego have found fungi in all 35 types of cancer studied. Other studies found people with certain species of fungi in their cancerous tumors had worse health outcomes. These findings can help researchers better understand the role of fungi in cancer cells.
3.
Diversifying Medicine: The Harper Cancer Research Institute partnered with the Pokagon Band of Potawatomi Indians to raise awareness about early detection in Native American communities. This will address disparities in treatment outcomes and help researchers diversify cancer tissue samples to create more personalized medicine for people of all races and ethnicities.
4.
Seek a Screen: Doctors and oncologists have noted a rise in breast cancer diagnoses in younger people. According to the CDC, most breast cancer diagnoses occur in women over 50, but one in 10 women diagnosed are under the age of 45. Every person with breasts, not just those over age 50, should pay attention to their bodies and get screened.
5.
Put to the Test: A molecular test that distinguishes between benign and malignant cysts shows promising results for pancreatic cancer. Funded by the U.S. National Cancer Institute, the Pancreatic Cancer Action Network and others, PancreaSeq will help improve early detection of pancreatic cancer and avoid overtreatment.
6.
Mediterranea-yum!: Researchers concluded that a Mediterranean diet rich in fiber, mono-unsaturated fatty acids (found in oils, nuts and fish) and polyphenols (found in vegetables, fruit and whole grains) has been associated with a major improved response to immunotherapy drugs, called immune checkpoint inhibitors, in melanoma patients. This diet was also associated with progression-free survival at 12 months.
7.
Embrace Your Curls: Be careful of chemical hair-straightening products. A study by the National Institute of Environmental Health Sciences followed almost 35,000 women between age 35 and 74 to monitor risk factors for breast cancer and other conditions, and found that women who frequently used hair-straightening products were more than twice as likely to develop uterine cancer.
8.
Good Genes: In a Swedish preclinical study of patients with clear-cell kidney cancer, researchers found the activity of four specific genes in the patients’ cancer cells may be able to predict the risk of tumors spreading to the skeleton, occurring in one-third of cases. The research will help scientists better understand the interaction between tumors and their microenvironment.
9.
Hand in Hand: Moderna and Merck have announced that together they will develop and sell a personalized cancer vaccine for individual patients. Moderna’s messenger RNA vaccine technology will be studied along with Merck’s Keytruda to treat patients with high-risk melanoma.
1.
Fighter T: Researchers at Johns Hopkins University are developing a vaccine to train T-cells to recognize and kill cells that have one of the six gene mutations that causes pancreatic cancer. The first clinical trial included 12 patients with pancreatic cancer who were treated with surgery. Two years later, these patients are still cancer-free!
2.
Fungus Among Us: Research from the Weizmann Institute of Science in Israel and the University of California, San Diego have found fungi in all 35 types of cancer studied. Other studies found people with certain species of fungi in their cancerous tumors had worse health outcomes. These findings can help researchers better understand the role of fungi in cancer cells.
3.
Diversifying Medicine: The Harper Cancer Research Institute partnered with the Pokagon Band of Potawatomi Indians to raise awareness about early detection in Native American communities. This will address disparities in treatment outcomes and help researchers diversify cancer tissue samples to create more personalized medicine for people of all races and ethnicities.
4.
Seek a Screen: Doctors and oncologists have noted a rise in breast cancer diagnoses in younger people. According to the CDC, most breast cancer diagnoses occur in women over 50, but one in 10 women diagnosed are under the age of 45. Every person with breasts, not just those over age 50, should pay attention to their bodies and get screened.
5.
Put to the Test: A molecular test that distinguishes between benign and malignant cysts shows promising results for pancreatic cancer. Funded by the U.S. National Cancer Institute, the Pancreatic Cancer Action Network and others, PancreaSeq will help improve early detection of pancreatic cancer and avoid overtreatment.
6.
Mediterranea-yum!: Researchers concluded that a Mediterranean diet rich in fiber, mono-unsaturated fatty acids (found in oils, nuts and fish) and polyphenols (found in vegetables, fruit and whole grains) has been associated with a major improved response to immunotherapy drugs, called immune checkpoint inhibitors, in melanoma patients. This diet was also associated with progression-free survival at 12 months.
7.
Embrace Your Curls: Be careful of chemical hair-straightening products. A study by the National Institute of Environmental Health Sciences followed almost 35,000 women between age 35 and 74 to monitor risk factors for breast cancer and other conditions, and found that women who frequently used hair-straightening products were more than twice as likely to develop uterine cancer.
8.
Good Genes: In a Swedish preclinical study of patients with clear-cell kidney cancer, researchers found the activity of four specific genes in the patients’ cancer cells may be able to predict the risk of tumors spreading to the skeleton, occurring in one-third of cases. The research will help scientists better understand the interaction between tumors and their microenvironment.
9.
Hand in Hand: Moderna and Merck have announced that together they will develop and sell a personalized cancer vaccine for individual patients. Moderna’s messenger RNA vaccine technology will be studied along with Merck’s Keytruda to treat patients with high-risk melanoma.
1.
Fighter T: Researchers at Johns Hopkins University are developing a vaccine to train T-cells to recognize and kill cells that have one of the six gene mutations that causes pancreatic cancer. The first clinical trial included 12 patients with pancreatic cancer who were treated with surgery. Two years later, these patients are still cancer-free!
2.
Fungus Among Us: Research from the Weizmann Institute of Science in Israel and the University of California, San Diego have found fungi in all 35 types of cancer studied. Other studies found people with certain species of fungi in their cancerous tumors had worse health outcomes. These findings can help researchers better understand the role of fungi in cancer cells.
3.
Diversifying Medicine: The Harper Cancer Research Institute partnered with the Pokagon Band of Potawatomi Indians to raise awareness about early detection in Native American communities. This will address disparities in treatment outcomes and help researchers diversify cancer tissue samples to create more personalized medicine for people of all races and ethnicities.
4.
Seek a Screen: Doctors and oncologists have noted a rise in breast cancer diagnoses in younger people. According to the CDC, most breast cancer diagnoses occur in women over 50, but one in 10 women diagnosed are under the age of 45. Every person with breasts, not just those over age 50, should pay attention to their bodies and get screened.
5.
Put to the Test: A molecular test that distinguishes between benign and malignant cysts shows promising results for pancreatic cancer. Funded by the U.S. National Cancer Institute, the Pancreatic Cancer Action Network and others, PancreaSeq will help improve early detection of pancreatic cancer and avoid overtreatment.
6.
Mediterranea-yum!: Researchers concluded that a Mediterranean diet rich in fiber, mono-unsaturated fatty acids (found in oils, nuts and fish) and polyphenols (found in vegetables, fruit and whole grains) has been associated with a major improved response to immunotherapy drugs, called immune checkpoint inhibitors, in melanoma patients. This diet was also associated with progression-free survival at 12 months.
7.
Embrace Your Curls: Be careful of chemical hair-straightening products. A study by the National Institute of Environmental Health Sciences followed almost 35,000 women between age 35 and 74 to monitor risk factors for breast cancer and other conditions, and found that women who frequently used hair-straightening products were more than twice as likely to develop uterine cancer.
8.
Good Genes: In a Swedish preclinical study of patients with clear-cell kidney cancer, researchers found the activity of four specific genes in the patients’ cancer cells may be able to predict the risk of tumors spreading to the skeleton, occurring in one-third of cases. The research will help scientists better understand the interaction between tumors and their microenvironment.
9.
Hand in Hand: Moderna and Merck have announced that together they will develop and sell a personalized cancer vaccine for individual patients. Moderna’s messenger RNA vaccine technology will be studied along with Merck’s Keytruda to treat patients with high-risk melanoma.
While the Chicago Wolves are proud of their four league championships, they feel just as proud of their relationship with hockey fans, which enabled Chicago Wolves Charities to raise more than $4 million for local organizations.
Author, actress, model and cancer warrior Sara Quiriconi shares her tips for a fulfilling life during and after cancer.
Light a candle, grab the weighted blanket and settle into your coziest corner because it’s time to chill out! Issue 12’s tracklist features meditative melodies perfect to kick back and relax with.
Meet issue 10’s cancer thriver, Kate Haleblian, who survived cancer right when her young adult life was about to begin.
The research behind the mRNA-based vaccines used to minimize severe COVID-19 cases has another potential use—fighting cancer.